How many UTIs constitute a recurrent UTI?

A recurrent UTI is medically defined as two or more confirmed urinary tract infections within a 6-month period, or three or more infections within a 12-month period.

Why do I keep getting UTIs even after taking antibiotics?

Recurrent UTIs despite antibiotic treatment can occur due to antibiotic resistance, reinfection, incomplete eradication, or underlying anatomical or hormonal factors. A specialist evaluation with urine culture is essential.

Can recurrent UTIs be prevented?

Yes - recurrent UTIs can often be significantly reduced or eliminated with the right prevention strategy including low-dose antibiotic prophylaxis, vaginal estrogen therapy for postmenopausal women, behavioral modifications, and evidence-based supplements.

Do I need to see an infectious disease specialist or can my primary care doctor treat recurrent UTIs?

While primary care physicians can treat individual UTI episodes, recurrent UTIs benefit significantly from infectious disease specialist evaluation with specialized training in antibiotic resistance patterns and evidence-based prevention strategies.

Is long-term antibiotic use for UTI prevention safe?

Low-dose antibiotic prophylaxis for recurrent UTI prevention has a well-established safety record when properly managed. Specialists carefully select the safest antibiotic at the lowest effective dose and regularly reassess.

Does Atlas IDP accept insurance for recurrent UTI treatment?

Yes, Atlas Infectious Disease Practice accepts most major insurance plans. Call (561) 995-6971 to verify your specific insurance coverage before your appointment.

Infectious Disease Archives

Cabotegravir Combined With Broadly Neutralizing Antibodies Maintains Undetectable HIV

Results from the LAPTOP Trial

Exploring Novel Dosing Strategies by Reducing Once Daily Biktarvy

Gilead’s Once-Yearly Lenacapavir Formulations Show Sustained Efficacy for HIV PrEP in Phase 1 Study

Initial Findings from IMC-M113V Trial for HIV Functional Cure Strategy Shows Potential

HIV Education and Advocacy in an Age of Uncertainty

HIV and Long COVID Insights from the RECOVER Program on Risk and Diagnosis

Measles: An Old Foe Has Returned

Bivalent HIV Vaccine Induces Stronger T Cell Responses in People with HIV on ART

Age-Related T Cell Response in People with HIV on ART in MVA.HIVconsvX Vaccine Trial

Schedule an Appointment

Quick Links

Patient Forms

Contact Us